Document:

Exhibit
10.7

 

HEALTH
SCIENCES ACQUISITIONS CORPORATION

412 West 15th Street, Floor 9

New York, NY 10011

 

                        ,
2019

 

Health
Sciences Holdings, LLC

412 West 15th Street, Floor 9

New York, NY 10011

 

Ladies
and Gentlemen:

 

This
letter will confirm our agreement that, commencing on the effective date (the “Effective Date”) of the
registration statement (the “Registration Statement”) for the initial public offering (the “IPO”)
of the securities of Health Sciences Acquisitions Corporation (the “Company”) and continuing until the
earlier of (i) the consummation by the Company of an initial business combination or (ii) the Company’s liquidation (in
each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination
Date”), Health Sciences Holdings, LLC (“Health Sciences Holdings”) shall make available
to the Company certain office space, secretarial and administrative services as may be required by the Company from time to time,
situated at 412 West 19th Street, Floor 9, New York, NY 10011 (or any successor location). In exchange therefore, the Company
shall pay Health Sciences Holdings a sum not to exceed $10,000 per month, respectively, on the Effective Date and continuing monthly
thereafter until the Termination Date. Health Sciences Holdings hereby agrees that it does not have any right, title, interest
or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust Account”)
that may be established by the Company for the benefit of the Company’s public stockholders upon the consummation of the
IPO as described in the Registration Statement ( “Claim”) and hereby waives any Claim it may have in
the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse
against the Trust Account for any reason whatsoever.

 

	 	 	 	Very truly yours,
	 	 	 	 	 
	 	 	 	HEALTH SCIENCES ACQUISITIONS CORPORATION
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	Name:
	 	 	 	Title:
	 	 	 	 	 
	AGREED TO AND ACCEPTED BY:	 	 	 
	 	 	 	 	 
	HEALTH SCIENCES HOLDINGS, LLC	 	 	 
	 	 	 	 	 
	By:	 	 	 	 
	Name:	 	 	 
	Title:Exhibit
10.8

 

                                  ,
2019

 

Health
Sciences Acquisitions Corporation

412 West 15th Street, Floor 9

New York, NY 10011

 

Ladies
and Gentlemen:

 

Health
Sciences Acquisitions Corporation (the “Company”), a blank check company formed for the purpose of acquiring
one or more businesses or entities (a “Business Combination”), intends to register its securities under the
Securities Act of 1933, as amended (“Securities Act”), in connection with its initial public offering (“IPO”),
pursuant to a registration statement on Form S-1 (“Registration Statement”).

 

Health
Sciences Holdings, LLC (the “Sponsor”) hereby commits that it will purchase an aggregate of 10,000,000 warrants
of the Company (“Private Warrants”), each Private Warrant entitling the holder thereof to purchase one-half
of one share of Common Stock of the Company, par value $0.0001 per share (the “Common Stock”), at $0.50 per
Private Warrant, for an aggregate purchase price of $5,000,000 (the “Private Warrant Purchase Price”).

 

At
least twenty-four (24) hours prior to the beginning of the road show relating to the IPO, the Sponsor will cause the Private Warrant
Purchase Price to be delivered to Loeb & Loeb LLP (“Loeb”), as escrow agent and counsel for the Company,
by wire transfer as set forth in the instructions attached as Exhibit A to hold in a non-interest bearing account until the Company
consummates the IPO.

 

The
consummation of the purchase and issuance of the Private Warrants shall occur simultaneously with the consummation of the IPO.
Simultaneously with the consummation of the IPO, Continental Stock Transfer & Trust Company (“Trustee”) shall
deposit the Private Warrant Purchase Price, without interest or deduction, into the trust fund (“Trust Fund”)
established by the Company for the benefit of the Company’s public stockholders as described in the Registration Statement.
If the Company does not complete the IPO within ten (10) days from the date of this letter, the Private Warrant Purchase Price
(without interest or deduction) will be returned to the Sponsor. 

 

Each
of the Company and the Sponsor acknowledges and agrees that Loeb is serving hereunder solely as a convenience to the parties to
facilitate the purchase of the Private Warrants and Loeb’s sole obligation under this letter agreement is to act with respect
to holding and disbursing the Purchase Price for the Private Warrants as described above. Loeb shall not be liable to the Company,
Chardan or the undersigned or any other person or entity in respect of any act or failure to act hereunder or otherwise in connection
with performing its services hereunder unless Loeb has acted in a manner constituting gross negligence or willful misconduct.
The Company and the undersigned shall indemnify Loeb against any claim made against it (including reasonable attorney’s
fees) by reason of it acting or failing to act in connection with this letter agreement except as a result of its gross negligence
or willful misconduct. . Loeb hereby agrees that it shall not have any right, title, interest or claim of any kind in or to any
monies that may be set aside in the Trust Fund (“Claim”) and hereby waives any Claim it may have in the future
as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against
the Trust Fund for any reason whatsoever

 

     

     

    

 

The
Private Warrants will be identical to the warrants to be sold by the Company in the IPO. Additionally, the Sponsor agrees:

 

		●	to
                                         vote the Common Stock included in the Private Warrants in favor of any proposed Business
                                         Combination;

 

		●	not
                                         to propose, or vote in favor of, an amendment to the Company’s Amended and Restated
                                         Certificate of Incorporation that would affect the substance or timing of the Company’s
                                         obligation to redeem 100% of the Company’s shares of Common Stock sold in the IPO
                                         if the Company does not complete an initial Business Combination within 24 months from
                                         the closing of the IPO, unless the Company provides the holders of shares of Common Stock
                                         sold in the IPO with the opportunity to redeem their shares of Common Stock upon approval
                                         of any such amendment at a per-share price, payable in cash, equal to the aggregate amount
                                         of the Trust Fund, including interest earned on Trust Fund and not previously released
                                         to the Company to pay the Company’s franchise and income taxes, divided by the
                                         number of then outstanding shares of Common Stock sold in the IPO;

 

		●	not
                                         to convert any shares of Common Stock included in the Private Warrants into the right
                                         to receive cash from the Trust Fund in connection with a shareholder vote to approve
                                         either a Business Combination or an amendment to the provisions of the Company’s
                                         Amended and Restated Certificate of Incorporation, and not to tender the Private Warrants
                                         in connection with a tender offer conducted prior to the closing of a Business Combination;

 

		●	the
                                         Sponsor will not participate in any liquidation distribution with respect to the Private
                                         Warrants (but will participate in liquidation distributions with respect to any units
                                         or Common Stock purchased by the Sponsor in the IPO or in the open market) if the Company
                                         fails to consummate a Business Combination;

 

		●	that
                                         the Private Warrants and underlying securities will not be transferable until after the
                                         consummation of a Business Combination except (i) to the Company’s pre-IPO stockholders,
                                         or to the Company’s officers, directors, advisors and employees, (ii) to the Sponsor’s
                                         affiliates or its members upon its liquidation, (iii) to relatives and trusts for estate
                                         planning purposes, (iv) by virtue of the laws of descent and distribution upon death,
                                         (v) pursuant to a qualified domestic relations order, (vi) by private sales at prices
                                         no greater than the price at which the Private Warrants were originally purchased or
                                         (vii) to the Company for cancellation in connection with the consummation of a Business
                                         Combination, in each case (except for clause vii) where the transferee agrees to the
                                         terms of the transfer restrictions; and

 

    2 

     

    

 

		●	the
                                         Private Warrants will include any additional terms or restrictions as is customary in
                                         other similarly structured blank check company offerings or as may be reasonably required
                                         by the underwriters in the IPO in order to consummate the IPO, each of which will be
                                         set forth in the Registration Statement.

 

The
Sponsor acknowledges and agrees that the purchaser of the Private Warrants will execute agreements in form and substance typical
for transactions of this nature necessary to effectuate the foregoing agreements and obligations prior to the consummation of
the IPO as are reasonably acceptable to the Sponsor, including but not limited to an insider letter.

 

The
Sponsor hereby represents and warrants that:

 

		(a)	it
                                         has been advised that the Private Warrants have not been registered under the Securities
                                         Act;

 

		(b)	it
                                         will be acquiring the Private Warrants for its account for investment purposes only;

 

		(c)	it
                                         has no present intention of selling or otherwise disposing of the Private Warrants in
                                         violation of the securities laws of the United States;

 

		(d)	it
                                         is an ‘“accredited investor” as defined by Rule 501 of Regulation D
                                         promulgated under the Securities Act;

 

		(e)	it
                                         has had both the opportunity to ask questions and receive answers from the officers and
                                         directors of the Company and all persons acting on its behalf concerning the terms and
                                         conditions of the offer made hereunder;

 

		(f)	it
                                         is familiar with the proposed business, management, financial condition and affairs of
                                         the Company;

 

		(g)	it
                                         has full power, authority and legal capacity to execute and deliver this letter and any
                                         documents contemplated herein or needed to consummate the transactions contemplated in
                                         this letter; and

 

		(h)	this
                                         letter constitutes its legal, valid and binding obligation, and is enforceable against
                                         it.

 

This
letter agreement constitutes the entire agreement between the Sponsor and the Company with respect to the purchase of the Private
Warrants, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written
and oral, with respect to the same.

 

    3 

     

    

 

	 	Very truly yours,
	 	 	 
	 	HEALTH SCIENCES HOLDINGS, LLC
	 	 	 
	 	By:	 
	 	Name:
	 	Title:

 

	Accepted and Agreed:
	 
	HEALTH SCIENCES ACQUISITIONS CORPORATION
	 
	By:	 	 
		Name:	 
		Title:	 
	 	 	 
	LOEB & LOEB LLP	 
	 	 
	By:	 	 
		Name:	 
		Title:	 
	 	 	 

 

    4 

     

    

 

Exhibit
A

 

Wire
Instructions

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]